Trial Profile
A Phase I, First-in-Human, Vehicle Controlled, Single Ascending Dose Trial Evaluating the Safety, Tolerability and Pharmacokinetics in Male Subjects With AD and in Healthy Male Subjects of Cutaneous Application of LEO 39652 Cream
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jan 2015
Price :
$35
*
At a glance
- Drugs LEO 39652 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; First in man
- Sponsors LEO Pharma
- 21 Jan 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Jan 2014 New trial record